Advaita Bio today announced the launch of iSCanGuide, a cloud-based platform engineered to transform large-scale single-cell and spatial transcriptomics datasets into biologically meaningful results.
GPU-Accelerated Platform Unifies Fragmented Workflows, Turning Weeks of Analysis into MinutesANN ARBOR, Mich., May 7, 2026 /PRNewswire/ -- Advaita Bio today announced the launch of iSCanGuide ...
Scar-driven changes in joint tissue may underlie treatment resistance in rheumatoid arthritis, opening the door to new ...
A new computational study led by UB scientists and published April 21 in Biophysical Journal sheds light on this understudied ...
A Moffitt Cancer Center researcher has introduced a new model that addresses one of biology's most fundamental questions: How does genetic information keep living systems organized and therefore alive ...
The FDA grants RMAT designation to Orca-Q, Orca Bio’s second-generation investigational allogeneic T-cell immunotherapy.
Orca Bio’s Orca-Q receives US FDA’s RMAT designation for treatment of high-risk hematologic malignancies: Menlo Park, California Thursday, April 30, 2026, 18:00 Hrs [IST] Orca ...
Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...
BOCA RATON, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company”), a clinical-stage ...
Continued site activation in registrational SAFEGUARD trial of SAB-142; enrollment ongoing and on track to be completed by end of 2026 with ...
This new research, published in the Genes & Diseases journal by a team from Chongqing Medical University and Southwest Medical University, investigated the precise mechanisms by which the long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results